COVID-19 ANALYSIS REPORT
Power BI Desktop
Region and Date
All
Total Tests
Total Population
Total Cases
Total Deaths
Total Recovered
6bn 268M 19M 713K 12M
Confirmed and Recovered cases by Month
% Population by Continent
South America 6,81%
Active Cases
North America
9,32%
6M
362,90M
Africa 21,24%
246,53M
199,59M
Europe
11,82%
144,99M
Australia/O…
0,65%
63,39M
Mortality Rate (%)
1,66M
January
February
March
15,94M
April
52,88M
May
June
Month
Asia 50,17%
6,12
0,04M
9,00M
116,98M
Sum of confirmed
Death cases by Month
Sum of recovered
WHO-Region by Continent
South America 6,52%
15,71M
13,31M
North America 13,04%
Africa 29,35%
9,61M
Cases per Capita
0,66
4,31M
Europe 23,91%
0,00M
0,05M
0,40M
January
February
March
April
Month
May
June
July
Australia/Oceania 2,17%
Asia 25%
July
COVID-19 ANALYSIS REPORT
Power BI Desktop
Region and Date
All
Total Tests
Total Population
Total Cases
Total Deaths
Total Recovered
6bn 268M 19M 713K 12M
Top 5 Regions by Active cases
Active Cases
Confirmed Cases by Top 5 Region
156,98M
US
6M
31,09M
Brazil
22,62M
United Kingdom
19,67M
Russia
©
©- Microsoft
Microsoft Corporation
Corporation
Mortality Rate (%)
15,99M
India
Recovered cases by WHO-Region
6,12
Americas
Sum of recovered 4,5M
who_region
Europe
Cases per Capita
0,66
New cases by Top 5 Region
Sum of recovered 2,0M
Eastern Mediterra…
Sum of recovered 1,2M
South-East Asia
Sum of recovered 1,2M
Africa
Sum of recovered 0,4M
Western Pacific
Sum of recovered 0,2M
0M
2M
Sum of recovered
4M
©
©- Microsoft
Microsoft Corporation
Corporation
Insights:
Power BI Desktop
• Our analysis revealed critical trends, such as regions with the highest mortality rates, daily case growth patterns, and the relationship between population density and infection rates.
Challenges:
• Key challenges included handling missing data, ensuring consistency across datasets, and optimizing dashboard performance. We addressed these through data cleaning, DAX measures, and efficient data modeling.
Recommendations
• Based on the insights, we recommend targeted resource allocation, enhanced testing in high-density areas, and prioritizing vaccination campaigns in regions with rising active cases.